Sputnik V import: India in price talks, DRL to import initial doses after regulatory nod

Sputnik V import: India in price talks, DRL to import initial doses after regulatory nod
SECTIONS
Share
Synopsis
Dr Reddy’s Laboratories has a tie-up with the Russian Direct Investment Fund, which backed the development of Sputnik V, and will import the initial doses of the vaccine once it gets approval from the drug regulator. Subsequent doses of the vaccine will be manufactured in India.
Agencies
Sputnik V’s efficacy is confirmed at 91.6% and it is one of three vaccines with an efficacy of over 90%.
The government is negotiating the price at which it will procure imported doses of Russia’s Covid-19 vaccine Sputnik V, which is at an advanced stage of the regulatory approval process in India.

Related Keywords

Moscow ,Moskva ,Russia ,India ,Russian ,Bharat ,Stelis Biopharma ,Gamaleya National Research Centre For Epidemiology ,Serum Institute Of India ,Russian Direct Investment Fund ,Serum Institute ,Bharat Biotech ,Local Manufacturers ,Hetero Biopharma ,Gland Pharma ,Vichrow Biotech ,Gamaleya National Research Centre ,மாஸ்கோ ,மோசிக்குவா ,ரஷ்யா ,இந்தியா ,ரஷ்ய ,பாரத் ,சீரம் நிறுவனம் ஆஃப் இந்தியா ,ரஷ்ய நேரடி முதலீடு நிதி ,சீரம் நிறுவனம் ,பாரத் பயோடெக் ,உள்ளூர் உற்பத்தியாளர்கள் ,சுரப்பி பார்மா ,